Correlation Between Novo Nordisk and Omeros
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Omeros at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Omeros into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Omeros, you can compare the effects of market volatilities on Novo Nordisk and Omeros and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Omeros. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Omeros.
Diversification Opportunities for Novo Nordisk and Omeros
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Novo and Omeros is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Omeros in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omeros and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Omeros. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omeros has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Omeros go up and down completely randomly.
Pair Corralation between Novo Nordisk and Omeros
Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the Omeros. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 3.27 times less risky than Omeros. The stock trades about -0.01 of its potential returns per unit of risk. The Omeros is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 313.00 in Omeros on September 24, 2024 and sell it today you would earn a total of 698.00 from holding Omeros or generate 223.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Novo Nordisk AS vs. Omeros
Performance |
Timeline |
Novo Nordisk AS |
Omeros |
Novo Nordisk and Omeros Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novo Nordisk and Omeros
The main advantage of trading using opposite Novo Nordisk and Omeros positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Omeros can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will offset losses from the drop in Omeros' long position.Novo Nordisk vs. CSL LTD SPONADR | Novo Nordisk vs. CSL Limited | Novo Nordisk vs. Mercedes Benz Group AG | Novo Nordisk vs. Vertex Pharmaceuticals Incorporated |
Omeros vs. Novo Nordisk AS | Omeros vs. CSL LTD SPONADR | Omeros vs. CSL Limited | Omeros vs. Mercedes Benz Group AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |